Gynesonics, Inc.的动态

A study published in The BMJ reveals that women with #endometriosis may face a 31% higher risk of premature death, largely due to gynecological cancers. The findings emphasize the importance of considering endometriosis and fibroids as part of a comprehensive approach to women’s long-term health, given their connections to chronic diseases and heightened health risks beyond reproductive years. Read more in this article from Medical Xpress: https://bit.ly/3V1NJ0p Heranova is addressing this critical need with HerResolve, a non-invasive, blood-based diagnostic test for the detection of endometriosis. By enabling earlier diagnosis, we aim to empower women and improve long-term health outcomes. Visit Heranova.com to learn more. #Heranova #HerResolve #WomensHealth

Discover the latest updates on The National Institutes of Health funding for #endometriosis research. Stay informed about the Eunice Kennedy Shriver?National Institute of Child Health and Human Development (NICHD) initiatives to support the development of new treatments for endometriosis here: https://bit.ly/3y2VwTf #Heranova #Womenshealth #Endocare

Diagnosing Endo. I have recently read two studies on diagnosing endometriosis and appreciate the efforts being made to find more affordable and less invasive diagnostic methods. Current statistics indicate that 10% of the female population has endometriosis. However, many women likely go undiagnosed due to a lack of resources, time, and finances. Additionally, I don't doubt many are misdiagnosed. Regardless of diagnosis, it is crucial to take care of ourselves. A key part of the healing journey is feeling heard and understood. That is why I coach women with endometriosis to address their lifestyle, whether they have been formally diagnosed or only suspect they have the disease. I have walked the path of recovery, much of it alone, and I am committed to helping others navigate their journey with support and understanding. (https://lnkd.in/g323WzNz & https://lnkd.in/grC7RAQj.)

Tufts Medicine's Dr. John Wong speaks about updated guidelines that: ?? All women 65+ should be screened for osteoporosis ?? Younger postmenopausal women at high fracture risk should also be screened ?? Not enough evidence to recommend screening men Read more here: https://lnkd.in/es8y4HCi

May is Women's Health Month, a crucial time to ensure women have access to the care and screenings they need. Supporting women's health involves a comprehensive approach with essential tests and preventive measures. Here are key recommendations: Pap Smear and HPV Test: Detect cervical cancer and HPV infections early. Mammogram: Screen for breast cancer, improving treatment success with early detection. Bone Density Test (DEXA Scan): Diagnose osteoporosis, particularly in postmenopausal women. Blood Pressure and Cholesterol Tests: Monitor cardiovascular health, vital for preventing heart disease. Blood Glucose Test: Screen for diabetes, aiding in effective management. STI Screenings: Essential for sexual and reproductive health. Mental Health Screenings: Address conditions like depression and anxiety for overall well-being. At IHDLab, we provide a wide range of diagnostic services to support women's health. Our goal is to offer accurate and timely testing to help women manage their health proactively. Let's work together to prioritize women's health through regular screenings and preventive care.

????Endometriosis Diagnostics ??? Imagine living with chronic pain that's often dismissed or misdiagnosed for years. This is the reality for millions of women with endometriosis. It's time we change that. ?? Shocking Facts: ??1 in 9 Australian women affected by age 44 ??7-10 years average delay in diagnosis ??$9.7 billion annual economic burden in Australia alone ??Up to 50% may face fertility challenges ?? The Hidden Struggle: Endometriosis isn't just about pain. It's missed workdays, strained relationships, and dreams of motherhood put on hold. Current diagnostic methods are invasive, inaccurate, and simply not good enough. ?? The Diagnostic Dilemma: ??Invasive laparoscopy remains the gold standard ??Reliance on visual identification, not specific biomarkers ??Non-invasive methods like ultrasound have limited accuracy ??Symptoms often mistaken for other conditions ??Lack of awareness among patients and some healthcare providers ??Normalisation of pain, leading to delayed seeking of care ??Limited access to specialists in some areas ?? Hope on the Horizon: At TC Life, we're not just talking about change - we're making it happen. We're on a mission to bring the most advanced, non-invasive diagnostic tools to market. ??Our Commitment: ??Assessing and introducing commercially viable biomarker-based solutions ??Collaborating with industry experts to ensure global access, starting in Australia ??Bridging the gap between innovative diagnostics and patient care Together, we can rewrite the story for millions of women suffering in silence. References: 1. Endometriosis research priorities in Australia. (https://lnkd.in/gJv5dAhJ) 2. The impact of endometriosis on work ability in young Australian women. (https://lnkd.in/gydvd9Cn) 3. Expression of Fucosyltransferase 4 (FUT4) mRNA Is Increased in Endometrium from Women with Endometriosis. (https://lnkd.in/dftnJiEA) #Endometriosis #EndometriosisAwareness #WomensHealth #HealthcareInnovation #MedicalDiagnostics #TCLife #PatientCare #HealthEconomics #MedicalTechnology #Pathology #Diagnostics #GlobalHealth #PatientSafety #RapidDiagnostics #ClinicalOutcomes #MedicalResearch #HealthcareSolutions #Innovation #Australia #USA #India #Collaboration #FutureOfHealthcare #NonInvasiveDiagnostics #WomenEmpowerment #ChronicPain #FertilityHealth #WorkplaceWellness #HealthEquity #MedicalInnovation #Endo #Endowarriors

?? Addressing Stroke Prevention Disparities ?? A recent study in the JAHA — Journal of the American Heart Association reveals a concerning disparity: women, especially Mexican American women, are less likely than men to take prescribed medications to prevent recurrent strokes. This is a critical issue, as secondary stroke prevention is essential to reducing risk and improving outcomes. ?? Key Insights: Mexican American women are 3x more likely than men to miss cholesterol-lowering medications. Caregiving roles, side effects, and perceptions about medication benefits may be barriers. Older and married women report higher rates of missed doses. At Alva Health, we are committed to empowering individuals with innovative solutions to better manage their health. This research highlights the urgent need for education, community support, and tools like wearable technology to help close the gap in care. Let’s work together to improve stroke outcomes for all. ?? Read more: https://lnkd.in/ef9SyzDc #StrokeCare #HealthEquity #Innovation #AlvaHealth #StrokeSurvivors

?? Neuroendocrinology Watch ?? highlighting: ???“The phenotype of the pediatric patient with Cushing syndrome but without obesity” ???Padilla C et al., EJE, 2024 ???https://lnkd.in/ewqwdf7W ???Key Findings: ??Age and Gender Differences: Non-obese patients were older at diagnosis and predominantly female. ??Puberty Stages: Non-obese patients were more likely to be at advanced Tanner stages. ??Blood Pressure Variance: Blood pressure stage at diagnosis varied significantly between obese and non-obese groups. ??Clinical Takeaway: Although weight gain is a hallmark feature of pediatric Cushing syndrome (CS), clinicians should screen for hypercortisolemia in children with other suspicious findings, even in the absence of obesity.

AccendoWave - A Pain #Data Company One example: Many drugs widely prescribed to older adults, including statins for high cholesterol, were studied mostly in men, with results extrapolated to women. “It’s assumed that women’s biology doesn’t matter and that women who are premenopausal and those who are postmenopausal respond similarly,” Faubion said. “This has got to stop: The FDA has to require that clinical trial data be reported by sex and age for us to tell if drugs work the same, better, or not as well in women,” Faubion insisted. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, #Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform. https://lnkd.in/gdfAHzQM

BioGrad has just launched Europe’s first private Women’s Health Research Tissue Bank in a groundbreaking ￡25M initiative. ??? This tissue bank is not just a milestone—it’s a game-changer for advancing personalized medicine in #womenshealth. With a significant focus on areas like #endometriosis, #PCOS, #breastcancer, and #infertility, this initiative will accelerate innovation and bridge the gaps in women’s health research that have persisted for far too long.